msp-1 (fmp-1) with as02a
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2003 (NCT00317473)
Timeline
2000s
- Jan 1, 2003
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- msp-1 (fmp-1) with as02a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00317473 | Phase 1 | Jun 1, 2003 | GlaxoSmithKline, Kenya Medical Research Institute, PATH, United States Agency for International Development, United States Army |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2003 |
| Kenya Medical Research Institute | Academic/Hospital | 1 | 0 | 1 | 2003 |
| PATH | Academic/Hospital | 1 | 0 | 1 | 2003 |
| United States Agency for International Development | Government | 1 | 0 | 1 | 2003 |
| United States Army | Government | 1 | 1 | 1 | 2003 |
5 organizations
Page 1 / 1